Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4295 results

Sort By:

User Evaluation of Advanced Personalized Modular Pressure Relief Seating Cushion Systems

Study ID: NCT03494127
Start Date: 2025-08-23
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Use of GEL BALL FITTED MODULAR CUSHION

Use of SQUISHINS FITTED MODULAR CUSHION

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.

Study ID: NCT06641648
Start Date: 2024-12-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

NK cell

Sponsor

Peking University First Hospital

Source: clinicaltrials.gov

Share:
Add to list

Neurologic Deficits and Recovery in Chronic Subdural Hematoma

Study ID: NCT05900557
Start Date: 2025-03
End Date: 2029-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

ECoG monitoring

Sponsor

University of New Mexico

Source: clinicaltrials.gov

Share:
Add to list

A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia

Study ID: NCT06678165
Start Date: 2024-12-31
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

3

Intervention / Treatment

YOLT-204

Sponsor

First Affiliated Hospital of Guangxi Medical University

Source: clinicaltrials.gov

Share:
Add to list

SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer

Study ID: NCT06666166
Start Date: 2024-12
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

28

Intervention / Treatment

SHR-A1811 & Apartinib

Sponsor

Y UNpeng lU

Source: clinicaltrials.gov

Share:
Add to list

Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers

Study ID: NCT06216366
Start Date: 2025-01-15
End Date: 2025-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Sodium Chloride 0.9% Inj pre-exposure

Sodium Chloride 0.9% Inj post-exposure

Recombinant human plasma gelsolin pre-exposure

Recombinant human plasma gelsolin post-exposure

Hyperbaric chamber

Sponsor

BioAegis Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list

An Exploratory Clinical Study of GC012F Injection for Refractory gMG

Study ID: NCT06419166
Start Date: 2024-12-01
End Date: 2027-10-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

18

Intervention / Treatment

GC012F injection

Sponsor

Zhejianguniversity

Source: clinicaltrials.gov

Share:
Add to list

Isatuximab in Lung Transplant Recipients

Study ID: NCT05862766
Start Date: 2024-12-01
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

6

Intervention / Treatment

Isatuximab

bone marrow biopsy

Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list

Insulin Resistance in Egyptian Patients With Multiple Sclerosis

Study ID: NCT06017726
Start Date: 2024-12
End Date: 2027-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

treatment of insulin resistance with appropriate modality according to each patient

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Ph I Trial of Cell Based Therapy for DMD

Study ID: NCT06692426
Start Date: 2024-12-16
End Date: 2027-03-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

8

Intervention / Treatment

MyoPAXon

Tacrolimus

Sponsor

Masonic Cancer Center, University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list